Hostname: page-component-6bf8c574d5-2jptb Total loading time: 0 Render date: 2025-02-21T06:53:37.254Z Has data issue: false hasContentIssue false
  • English
  • Français

Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan

Published online by Cambridge University Press:  01 March 1998

A. J. CLEARE ,
R. M. MURRAY ,
R. A. SHERWOOD  and
V. O'KEANE
A. J. CLEARE
Affiliation:
From the Department of Psychological Medicine, Institute of Psychiatry and Department of Clinical Biochemistry, King's College School of Medicine and Dentistry, London; and Addenbrooke's NHS Trust, Cambridge
R. M. MURRAY
Affiliation:
From the Department of Psychological Medicine, Institute of Psychiatry and Department of Clinical Biochemistry, King's College School of Medicine and Dentistry, London; and Addenbrooke's NHS Trust, Cambridge
R. A. SHERWOOD
Affiliation:
From the Department of Psychological Medicine, Institute of Psychiatry and Department of Clinical Biochemistry, King's College School of Medicine and Dentistry, London; and Addenbrooke's NHS Trust, Cambridge
V. O'KEANE
Affiliation:
From the Department of Psychological Medicine, Institute of Psychiatry and Department of Clinical Biochemistry, King's College School of Medicine and Dentistry, London; and Addenbrooke's NHS Trust, Cambridge
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background. Sumatriptan, a specific agonist at 5-HT1D receptors, stimulates release of growth hormone (GH) and inhibits release of prolactin (PRL).

Methods. We gave sumatriptan (6 mg subcutaneously) to 11 patients with unipolar major depression and 11 control subjects matched for age, sex, weight and menstrual cycle phase. Serum GH and PRL were measured at 0, 15, 30, 45, 60 and 90 min after injection.

Results. The maximal rise in GH was significantly reduced in the depressed patients, with 60% showing no increase over baseline compared with 18% of controls. There were no significant differences in PRL responses.

Conclusions. These results suggest reduced sensitivity of 5-HT1D receptors in major depression. Our results and those of studies investigating 5-HT1A receptors imply that both 5-HT1A and 5-HT1D autoreceptors may show reduced function in major depression.

Type
Research Article
Information
Psychological Medicine , Volume 28 , Issue 2 , March 1998 , pp. 295 - 300
Copyright
© 1998 Cambridge University Press